Browsing Tag
U.S. Securities and Exchange Commission
10 posts
Aquarian Capital wins shareholder approval for $4.1bn Brighthouse Financial, Inc. buyout (Nasdaq: BHF)
Brighthouse Financial, Inc. wins shareholder approval for a $4.1B Aquarian Capital LLC merger at $70 per share. Read what it means for investors and insurers.
VerifyMe, Inc. and Open World Ltd. sign definitive merger agreement to build cross-border digital asset infrastructure (NASDAQ: VRME)
VerifyMe, Inc. merges with Open World Ltd. to target real-world asset tokenization. Explore the strategic, regulatory, and market implications now.
FingerMotion Moves Toward Non-Cash Dividend Strategy: What the Pending Warrant Terms Could Mean for FNGR Stock
Find out how FingerMotion’s planned warrant-based dividend could shift shareholder value, liquidity strategy, and FNGR’s long-term capital approach.
Why Safe Pro’s $100m shelf registration is stirring investor debate on capital strategy
Safe Pro (NASDAQ: SPAI) has filed a $100 million mixed securities shelf. Find out whether it signals growth potential or looming dilution risk.
Texas Stock Exchange gains SEC approval, opening a new era of competition in U.S. capital markets
The SEC has approved TXSE Group’s Texas Stock Exchange, creating new competition for NYSE and Nasdaq. Find out how TXSE could reshape U.S. markets.
Alpine Securities loses Supreme Court battle over FINRA’s regulatory power
U.S. Supreme Court declines Alpine Securities' FINRA appeal, reinforcing the self-regulator’s power to oversee broker-dealers under SEC supervision.
EverBank Financial secures final approval for Sterling Bank acquisition
EverBank Financial Corp has secured final regulatory approval to acquire Sterling Bank and Trust, F.S.B., in a $261…
Adani Group faces fallout as TotalEnergies halts investments over $265m bribery charges
French multinational TotalEnergies has halted further financial contributions to its joint ventures with India’s Adani Group after the…
Will Lifeway Foods sell? Danone raises offer in battle for probiotic leader
Lifeway Foods, Inc. (NASDAQ: LWAY), a leader in kefir and probiotic fermented dairy products, has confirmed receiving a…
Cassava Sciences fined $40m over misleading Alzheimer’s drug trial results
In a sensational revelation, Cassava Sciences, Inc., a biotechnology company that has been the center of attention for…